Vireo Growth (VREOF) Times Interest Earned (2020 - 2026)
Vireo Growth (VREOF) reported Times Interest Earned of $0.03 for Q1 2026, down 86.79% on a YoY basis from $0.26 in Q1 2025, and up 114.47% sequentially from -$0.24 in Q4 2025.
Vireo Growth (VREOF) Times Interest Earned (2020 - 2026) Analysis & Trends
Vireo Growth (VREOF) has 7 years of Times Interest Earned data on file, last reported at $0.03 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned fell 86.79% year-over-year to $0.03; the trailing twelve-month figure through Mar 2026 stood at $0.02 (down 89.69% YoY), and the FY2025 full-year result was -$0.04, down 108.63% from the prior year.
- Times Interest Earned rose to $0.03 in Q1 2026, from -$0.24 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $0.8 in Q4 2023 to a low of -$0.24 in Q4 2025.
- A 5-year average of $0.12 and a median of $0.02 in 2022 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned sank 705.92% in 2023 and jumped 15392.9% in 2024, its largest moves.
- Tracing VREOF's Times Interest Earned over 5 years: stood at $0.1 in 2022, then jumped by 708.91% to $0.8 in 2023, then slumped by 103.98% to -$0.03 in 2024, then plunged by 657.75% to -$0.24 in 2025, then soared by 114.47% to $0.03 in 2026.
- Business Quant data shows VREOF's Times Interest Earned at $0.03 in Q1 2026, -$0.24 in Q4 2025, and $0.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.03 |
| Dec 31, 2025 | -0.24 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | -0.03 |
| Mar 31, 2025 | 0.26 |
| Dec 31, 2024 | -0.03 |
| Sep 30, 2024 | 0.52 |
| Jun 30, 2024 | 0.02 |
| Mar 31, 2024 | 0.24 |
| Dec 31, 2023 | 0.80 |
| Sep 30, 2023 | 0.74 |
| Jun 30, 2023 | -0.12 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.10 |
| Sep 30, 2022 | -0.02 |
| Jun 30, 2022 | 0.02 |
| Mar 31, 2022 | -0.22 |
| Dec 31, 2021 | -1.69 |
| Sep 30, 2021 | -0.02 |
| Jun 30, 2021 | -0.04 |